In: Social Issues

Submitted By hamizahtalhah
Words 2097
Pages 9
Task 2
1. Understanding motor controls / Stephen L. Herman. Category of works | Main Entry & Heading | Added Entry & Heading | Rules | Works of single personal authorship | Herman, Stephen L. | i. Title. | Entry: 21.4Heading: |

2. An introduction to equity derivatives: theory and practice / Saebastien Bossu & Philippe Henrotte Category of works | Main Entry & Heading | Added Entry & Heading | Rules | Shared responsibility with two person | Bossu, Saebastien. | i. Henrotte, Philippe. ii. Title. | Entry: 21.6BHeading: 22.5 |

3. Strategic marketing / Todd A. Mooradian, Kurt Matzler, Lawrence Kick Category of works | Main Entry & Heading | Added Entry & Heading | Rules | Shared responsibility with three person | Mooradian, Todd A. | i. Matzler, Kurt. ii. Kick Lawrence. iii. Title. | Entry: 21.30AHeading:21.6 |

4. Management the essentials / Stephen Robbins, Steve Mariotti, Caroline Glackin. And Naresh K. Roshan Category of works | Main Entry & Heading | Added Entry & Heading | Rules | Shared responsibility with four person | Robbins, Stephen. | i. Mariotti, Steve. ii. Glackin, Caroline. iii. Roshan, Naresh K. iv. Title. | Entry:21.6C2Heading: |

5. Advertising & IMC: principles & practice / Sandra Moriarty and Nancy Mitchell; edited by William Wells Category of works | Main Entry & Heading | Added Entry & Heading | Rules | Mixed responsibility | Mariarty, Sandra. | i. Mitchell, Nancy. ii. Wells, William. iii. Title. | Entry: 21.6B2Heading: 21.8 |

6. Organizational behavior / Prof. John R. Schermerhorn …[et al.]. Category of works | Main Entry & Heading | Added Entry & Heading | Rules | Shared responsibility | Organizational behavior | i. Schermerhom, John R, Prof. …[et al.]. ii. Title. | Entry:21.6c2Heading: |

7. Communicating in the…...

Similar Documents

Japan Case Study

...Incorporated and AFLAC sales associates have contributed over $34 million to the AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta.  • In 2004, AFLAC contributed $250,000 to CureSearch toward the Adolescent and Young Adult Programs.  • AFLAC has an ongoing commitment to the Child Life Therapy program at the Morrell Center for Childhood Cancer and Blood Disorders, which is housed in the Children's Hospital at Albany Medical Center.  • AFLAC has an ongoing commitment to the University of Nebraska Medical Center to establish the AFLAC Fund for Childhood Cancer Patients and Families. • In 1999, AFLAC became a founding sponsor of the American Association of Cancer Research (AACR) and has an ongoing commitment with the AACR to continue and expand the travel awards program and other initiatives designed to meet the needs of early career cancer investigators.  • In 1997, AFLAC committed $1.5 million to establish the AFLAC Chair for Cancer Research at USC/Norris Comprehensive Cancer Center in Los Angeles.  National Recognition • In 2007, AFLAC was named to Fortune magazine's list of the 100 Best Companies to Work For in America for the ninth consecutive year.  • In March 2007, Fortune magazine named AFLAC to its list of America's Most Admired Companies for the seventh consecutive year. • In June 2007, Black Enterprise magazine named AFLAC to its list of the 40 Best Companies for Diversity for the third......

Words: 8401 - Pages: 34

Distinct Entities or Dynamically Regulated Phenotypes

...2012;72:576-580. Updated version Access the most recent version of this article at: http://cancerres.aacrjournals.org/content/72/3/576 Cited Articles Citing articles This article cites by 32 articles, 10 of which you can access for free at: http://cancerres.aacrjournals.org/content/72/3/576.full.html#ref-list-1 This article has been cited by 2 HighWire-hosted articles. Access the articles at: http://cancerres.aacrjournals.org/content/72/3/576.full.html#related-urls E-mail alerts Reprints and Subscriptions Permissions Sign up to receive free email-alerts related to this article or journal. To order reprints of this article or to subscribe to the journal, contact the AACR Publications Department at pubs@aacr.org. To request permission to re-use all or part of this article, contact the AACR Publications Department at permissions@aacr.org. Downloaded from cancerres.aacrjournals.org on February 1, 2014. © 2012 American Association for Cancer Research. Review Cancer Research Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes? Yunqing Li1,2 and John Laterra1,2,3,4 Abstract The origins of tumor-propagating neoplastic stem-like cells [cancer stem cells (CSC)] and their relationship to the bulk population of tumor cells that lack stem-like tumor-propagating features (i.e., transit-amplifying cancer progenitor cells) remain unclear. Recent findings from multiple laboratories show that cancer progenitor cells have the capacity to......

Words: 3898 - Pages: 16

There Once Was a Young Wild Pony

...zwd zwe zwf zwg zwh zwi zwj zwk zwl zwm zwn zwo zwp zwq zwr zws zwt zwu zwv zww zwx zwy zwz zxa zxb zxc zxd zxe zxf zxg zxh zxi zxj zxk zxl zxm zxn zxo zxp zxq zxr zxs zxt zxu zxv zxw zxx zxy zxz zya zyb zyc zyd zye zyf zyg zyh zyi zyj zyk zyl zym zyn zyo zyp zyq zyr zys zyt zyu zyv zyw zyx zyy zyz zza zzb zzc zzd zze zzf zzg zzh zzi zzj zzk zzl zzm zzn zzo zzp zzq zzr zzs zzt zzu zzv zzw zzx zzy zzz aaaa aaab aaac aaad aaae aaaf aaag aaah aaai aaaj aaak aaal aaam aaan aaao aaap aaaq aaar aaas aaat aaau aaav aaaw aaax aaay aaaz aaba aabb aabc aabd aabe aabf aabg aabh aabi aabj aabk aabl aabm aabn aabo aabp aabq aabr aabs aabt aabu aabv aabw aabx aaby aabz aaca aacb aacc aacd aace aacf aacg aach aaci aacj aack aacl aacm aacn aaco aacp aacq aacr aacs aact aacu aacv aacw aacx aacy aacz aada aadb aadc aadd aade aadf aadg aadh aadi aadj aadk aadl aadm aadn aado aadp aadq aadr aads aadt aadu aadv aadw aadx aady aadz aaea aaeb aaec aaed aaee aaef aaeg aaeh aaei aaej aaek aael aaem aaen aaeo aaep aaeq aaer aaes aaet aaeu aaev aaew aaex aaey aaez aafa aafb aafc aafd aafe aaff aafg aafh aafi aafj aafk aafl aafm aafn aafo aafp aafq aafr aafs aaft aafu aafv aafw aafx aafy aafz aaga aagb aagc aagd aage aagf aagg aagh aagi aagj aagk aagl aagm aagn aago aagp aagq aagr aags aagt aagu aagv aagw aagx aagy aagz aaha aahb aahc aahd aahe aahf aahg aahh aahi aahj aahk aahl aahm aahn aaho aahp aahq aahr aahs aaht aahu aahv aahw aahx aahy aahz aaia aaib aaic aaid aaie aaif aaig aaih aaii aaij aaik......

Words: 29642 - Pages: 119

Sjdldslalnl Nsamdlkamdlk

...PD-1/PD-L1 for Hematological Malignancies - Drug Profile Product Description Mechanism of Action R&D Progress Ferritizumab - Drug Profile Product Description Mechanism of Action R&D Progress Hodgkin Lymphoma - Recent Pipeline Updates Hodgkin Lymphoma - Dormant Projects Hodgkin Lymphoma - Discontinued Products Hodgkin Lymphoma - Product Development Milestones Featured News & Press Releases May 14, 2014: Investigational PD-1 Immune Checkpoint Inhibitor Nivolumab Receives U.S. FDA Breakthrough Therapy Designation for Hodgkin Lymphoma Apr 10, 2014: Affimed Highlights Further Data on AFM13, a Bispecific CD30/CD16A TandAb in Development to Treat Hodgkin Lymphoma, at the 2014 AACR Annual Meeting Apr 07, 2014: TG Therapeutics Announces Preclinical Poster Presentations for TGR-1202 at AACR 2014 Feb 27, 2014: Seattle Genetics Highlights ADCETRIS Clinical Data at the 2014 Bone Marrow Transplant Tandem Meetings Jan 17, 2014: Seattle Genetics Announces ADCETRIS Approval in Japan for the Treatment of Relapsed or Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Dec 05, 2013: TG Therapeutics Announces Poster Presentations for TGR-1202 at the Upcoming 55th American Society of Hematology Meeting Oct 11, 2013: Seattle Genetics Highlights ADCETRIS (Brentuximab Vedotin) Clinical Data in the Frontline Setting at the International Symposium on Hodgkin Lymphoma Sep 16, 2013: Affimed Therapeutics and The Leukemia & Lymphoma Society Partner to Advance AFM13 in......

Words: 2420 - Pages: 10


...Progress for DVA Education Benefits To receive Department of Veterans Affairs (DVA) education benefits, a student must maintain satisfactory academic progress (SAP) and conduct. Accordingly, benefits will be terminated for individuals who are disqualified, suspended or expelled from the University. Academic Probation Academic probation (AP) shall occur when a grade point average (GPA) falls below acceptable levels for the program. Probation lasts for a period of four consecutive program-applicable courses. Concurrent enrollment is prohibited during the four-course AP sequence. Associate degree students enrolled at the online campus should continue traditional block scheduling format with concurrent enrollment in two courses (excluding AACR and AAPF). In graduate programs, the four-course sequence excludes any undergraduate prerequisite courses. Financial aid students will continue to receive funds during the probationary period. Veteran students will continue to receive DVA education benefits during the probation period. The veteran will be informed of the probation, and a notation to the student DVA file will be recorded when the probationary period commenced. Academic Disqualification Academic disqualification (AD) will result if a student fails to clear an academic probation status within four courses from the onset of probation. Veteran students will not be eligible for DVA educational benefits after disqualification. The DVA and student will be......

Words: 50205 - Pages: 201

There Is No Hope of Doing Perfect Research (Griffiths, 1998, P97).

...attaining higher levels of achievement, but the truth is that perfection is hard to achieve because there is always room for improvement. Works Cited Avendano, Carmen and Menendez, Carlos. A Brief Comment about Cancer Nanotechnology; Medicinal Chemistry of Anticancer Drugs. United Kingdom: Elseiver, 2008. Print. 1-7. Print LaMorte, Christopher and Lilly, John. “Computers: History and Development.” Jones Telecommunications and Multimedia Encyclopedia. n.d. Web. Meyers, Jeremy. “A Short History of the Computer (b.c. - 1993a.d.).” n.d. 1993: 2-8. Print. O'Grady, Jason D. Origin and History: Apple Inc. United States: Greenwood press, 2009. 1-16. Print. Weinstein, Bernard and Case, Kathleen. The History of Cancer Research: Introducing an AACR Centennial Series. Cancer Research. 23 July 2008. Web 2011. Wong, John. “Turning Research into Viable Cancer Drugs.” Genetic Engineering & Biotechnology News. 28.12: 15 June. 2008. Web 2011....

Words: 1033 - Pages: 5

Leukemia and Lymphoma Society

...tissue [Abstract]. ASH Annual Meeting 2001 (Published) Porcu P., Farag S., Marcucci G., Avalos B., Rhoades C., Fisher B., Byrd J.C., Grever M.R. and Caligiuri M.A. 2001. Phase I trial of interleukin-2 (IL-2) and rituximab in patients with relapsed or refractory B-cell lymphomas (R/R-BCL). ASH Annual Meeting 2001. No. Abstr. #4710 [Peer Reviewed] (Published) Porcu P., Pelletier R.P., Davis E.A., Baiocchi R.A., Eisenbeis C.F., Roychowdhury S., Nuovo G.J., Marsh W., Vanbuskirk A., Henry M.L., Ferguson R.M., Caligiuri M.A. 2001. Post-transplant lymph proliferative disorders following renal auto grafting: immunological and molecular monitoring identifies correlates of clinical response to reduction of immunosuppressant and antiviral therapy. AACR Annual Meeting 2001. New Orleans, LA. ...

Words: 3698 - Pages: 15

The Current State - Is the Catalog Relevant?

...task of building the next ILS ourselves." (jester, 1) wonderful. Why aren’t you on the committee? This is exactly the kind of no-nonsense thinking that needs to be out there. Libraries and librarians need to take a stand. We need "to get control again over our data and how we present it to patrons." (jester, 1) We need to move from discussion to action. Hear hear. ----------------------SOURCES--------------- Miller, Dick R. "XML and MARC: A Choice or Replacement." LAL. MARBI/CC:DA Joint Meeting. Chicago, IL. 2000. 8 Dec. 2007 . Danskin, Alan. "Tomorrow never knows: the end of cataloguing?" World Library and Information Congress. Seoul. 2006. 5 Dec. 2007 . Tillett, Barbara B. "Principles of AACR." Joint Steering Committee for Revision of AACR: Principles of AACR. 8 May 2006. 7 Dec. 2007 Tennant, Roy. "MARC Must Die." LibraryJournal.Com. 15 Oct. 2002. 8 Dec. 2007 . Calhoun, Karen. "The 'Changing Nature' of Cataloging." May 2006. 8 Dec. 2007 . Digital Content Strategies and Resources. "Endeavor, EBSCO Partner for XML Gateway Development." econtentmag.com. 21 May 2004. 8 Dec. 2007 . MARCXML. "MARC 21 XML Schema." MARC 21 XML Schema Official Website. 26 July 2006. 8 Dec. 2007 . Bowman, J H. Essential Cataloguing. London: Facet, 2003. 8. jester. "Is the Writing on the Wall for the Integrated Library System?" 13 Jun. 2006. 8 Dec. 2007 ....

Words: 1755 - Pages: 8